Jeffrey Klausner, MD, MPH
Jeffrey Klausner, MD, MPH, (Program Co-Director/Faculty Mentor) is Professor of Medicine and Global Health in the Division of Infectious Diseases. Dr. Klausner’s work focuses on biomedical aspects of HIV/STI control and sexual health as a core component of HIV prevention. Through his previous work as Director of STD Prevention and Control for the San Francisco Department of Public Health and Chief of the HIV/TB Care and Treatment Branch for the CDC-South Africa, he has integrated HIV and STI research with public health systems for surveillance, diagnosis, treatment, and prevention.
Innovative technologies for HIV/STI prevention
Public health systems for HIV/STI control
Bolan RK, Beymer MR, Weiss RE, Flynn RP, Leibowitz AA, Klausner JD. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study. Sex Transm Dis. 2015 Feb;42(2):98-103.
Espinosa K, Park JA, Gerrity JJ, Buono S, Shearer A, Dick C, Mak ML, Teramoto K, Klausner JD, Pandori M, Hess D. Fluoroquinolone resistance in Neisseria gonorrhoeae after cessation of ciprofloxacin usage in San Francisco: using molecular typing to investigate strain turnover. Sex Transm Dis. 2015 Feb;42(2):57-63.
Bristow CC, Leon SR, Ramos LB, Vargas SK, Flores JA, Konda KA, Caceres CF, Klausner JD. Laboratory Evaluation of a Dual Rapid Immunodiagnostic Test for HIV and Syphilis Infection. Journal of Clinical Microbiology. 2014.
Cabeza J, García PJ, Segura E, García P, Escudero F, La Rosa S, León S, Klausner JD. Feasibility of Chlamydia trachomatis screening and treatment in pregnant women in Lima, Peru: a prospective study in two large urban hospitals. Sex Transm Infect. 2015 Feb;91(1):7-10.